D-0246-2025 Class II

Recalled by Padagis US LLC — Minneapolis, MN

FDA drug recall D-0246-2025 was initiated by Padagis US LLC on Feb 6, 2025 and is designated Class II. Reason for recall: Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product. Affected quantity: 4944 cartons.

Recall details

Product Type
Drugs
Report Date
Mar 5, 2025
Initiation Date
Feb 6, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4944 cartons

Product description

Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per carton, Rx Only, For Topical Use Only, Manufactured by Padagis, Yeruham, Israel, NDC: 45802-0134-30

Reason for recall

Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.

Distribution pattern

Nationwide in the USA

Code information

Lot # 193109; Exp. 07/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0246-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0246-2025. Report a data issue: hello@regdatalab.com.